Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 35, Issue 1, Pages 33-40
Publisher
Springer Nature
Online
2013-10-21
DOI
10.1038/aps.2013.130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fingolimod phosphate promotes the neuroprotective effects of microglia
- (2013) Hiromi Noda et al. JOURNAL OF NEUROIMMUNOLOGY
- Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats
- (2012) Qiao-Juan Shi et al. BRAIN RESEARCH
- Inflammatory Cytokines in Experimental and Human Stroke
- (2012) Kate Lykke Lambertsen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Hypoxia-Induced Activation ofN-methyl-D-aspartate Receptors Causes Retinal Ganglion Cell Death in the Neonatal Retina
- (2012) Charanjit Kaur et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Inhibitory effects of diallyl disulfide on the production of inflammatory mediators and cytokines in lipopolysaccharide-activated BV2 microglia
- (2012) Hye Young Park et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats
- (2011) Rui Zhao et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats
- (2011) C.Z. Zhao et al. NEUROSCIENCE
- International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions
- (2011) M. Back et al. PHARMACOLOGICAL REVIEWS
- Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure
- (2011) Yun Wang et al. TOXICOLOGY LETTERS
- Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor
- (2010) F Wunder et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of microglia in amyloid clearance from the AD brain
- (2010) C. Y. Daniel Lee et al. JOURNAL OF NEURAL TRANSMISSION
- Montelukast, A Selective Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces Cerulein-Induced Pancreatic Injury in Rats
- (2010) Erkan Özkan et al. PANCREAS
- Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics
- (2010) R.K. Singh et al. PHARMACOLOGY
- Ligand-Induced Tyrosine Phosphorylation of Cysteinyl Leukotriene Receptor 1 Triggers Internalization and Signaling in Intestinal Epithelial Cells
- (2010) Ladan Parhamifar et al. PLoS One
- Microglia: biology and pathology
- (2009) Manuel B. Graeber et al. ACTA NEUROPATHOLOGICA
- Microglial Physiology: Unique Stimuli, Specialized Responses
- (2009) Richard M. Ransohoff et al. Annual Review of Immunology
- Interleukin-1 beta targeted therapy for type 2 diabetes
- (2009) Kathrin Maedler et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Differential kinase requirement for enhancement of FcγR-mediated phagocytosis in alveolar macrophages by leukotriene B4 vs. D4
- (2009) M.R.M. Campos et al. MOLECULAR IMMUNOLOGY
- Debris clearance by microglia: an essential link between degeneration and regeneration
- (2008) H. Neumann et al. BRAIN
- Interleukin-1β: a bridge between inflammation and excitotoxicity?
- (2008) Birgit Fogal et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now